LNCaP thus represent a cell cancer model refractory to Phoenix Rising in spite of caspase-3 activation and PGE-2 production, suggesting that the signaling axis is interrupted, possibly at the level of PGE-2 signal perception or processing. This evidence concerns the gene CASP3 and cancer.